Spyre Therapeutics Inc (SYRE) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Spyre Therapeutics Inc   (NASDAQ: SYRE)

Spyre Therapeutics Inc

Officers & Directors


Scott Burrows
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Michael Henderson, M.D.
Director


Austin, Texas

Russell J. Cox
Chairman of the Board

Laurie Stelzer
Director

Jeffrey W. Albers
Director

Mark McKenna
Director

Peter Harwin
Director

Cameron Turtle, D.Phil
President and Chief Executive Officer and Director

Tomas Kiselak
Director ,

Spyre Therapeutics Inc currently has 102 employees.






SYRE Management Effectiveness SYRE Revenue per Employee SYRE Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.